Skip to main content
OpenTrials

Clinical trial condition

Digestive System Neoplasms

Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.

14,203 public trials 3,225 recruiting studies
Refine in advanced search Browse all conditions

Digestive System Neoplasms trial results

Recruiting

Evaluating the Prognostic Capability of ctDNA as a Biomarker in Pancreatic Cancer Patients Undergoing Neoadjuvant Chemotherapy

NCT04616131

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Northwestern Medicine Cancer Center Kishwaukee DeKalb, Illinois, United States
  • Northwestern Medicine Cancer Center Delnor Geneva, Illinois, United States
  • Northwestern Medicine Cancer Center Warrenville Warrenville, Illinois, United States
View Trial Details
Recruiting

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

NCT07503808

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +48 more
Locations
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • START New York Long Island, LLC Lake Success, New York, United States
View all 15 locations
View Trial Details
Recruiting

BOLSTER: Learning New Skills to Thrive

NCT06936878

Conditions
Advanced Cancer, Digestive System Diseases, Digestive System Neoplasms, +6 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

NCT06586515

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +19 more
Locations
  • City of Hope Duarte, California, United States
  • University of California, Los Angeles (UCLA) Santa Monica, California, United States
  • Sarah Cannon Research Institute at HealthOne Denver, Colorado, United States
  • Sibley Memorial Hospital Washington D.C., District of Columbia, United States
View all 52 locations
View Trial Details
Recruiting

A Phase I, First in Human Study of CBA-1205, Anti-DLK1 Monoclonal Antibody in Patients With Advanced Solid Tumors, Hepatocellular Carcinoma (HCC), Melanoma, and Pediatric Cancer

NCT06636435

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +21 more
Locations
  • National Cancer Center Hospital East Kashiwa, Chiba, Japan
  • Kanagawa Cancer Center Yokohama, Kanagawa, Japan
  • Niigata University Medical and Dental Hospital Niigata, Japan
  • National Cancer Center Hospital Chūō, Tokyo, Japan
View Trial Details
Recruiting

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

NCT05786924

Conditions
Acquired Resistance to KRAS G12C Inhibitor, BRAF, BRAF Gene Mutation, +61 more
Locations
  • Banner Health- MD Anderson Cancer Center Gilbert, Arizona, United States
  • The Angeles clinic - A cedars SINAI AFFILIATE Los Angeles, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California, San Francisco (UCSF) San Francisco, California, United States
View all 27 locations
View Trial Details

Related conditions